Subcutaneous Testosterone Project

NCT02229617 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Gender Dysphoria

Interventions

DRUG: Subcutaneous testosterone

Sponsor

University of British Columbia

Collaborators

[object Object]